Trademark: 87745494
Word
SYMPLEITOPE
Status
Dead
Status Code
606
Status Date
Monday, March 9, 2020
Serial Number
87745494
Mark Type
4000
Filing Date
Friday, January 5, 2018
Published for Opposition
Tuesday, December 11, 2018
Abandoned Date
Monday, March 9, 2020

Trademark Owner History
Compass Therapeutics LLC - Owner At Publication

Classifications
1 Biological preparations, namely, Antigen-binding molecules for scientific and research purposes
5 Biological Antigen-binding molecules for medical purposes for human medical diagnostics and analysis; Biological therapeutic preparations for the prevention and treatment of cancer, inflammatory diseases, and transplant rejection
42 Custom selection, design, and development of antigen-binding molecules for scientific, research, human medical diagnostics and analysis purposes and antigen-binding molecule therapeutic preparations for the prevention and treatment of cancer, inflammatory diseases, and transplant rejection

Trademark Events
Mar 9, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 9, 2020
Abandonment - No Use Statement Filed
Jul 31, 2019
Notice Of Approval Of Extension Request E-Mailed
Jul 29, 2019
Extension 1 Granted
Jul 29, 2019
Extension 1 Filed
Jul 29, 2019
Teas Extension Received
Feb 5, 2019
Noa E-Mailed - Sou Required From Applicant
Dec 11, 2018
Official Gazette Publication Confirmation E-Mailed
Dec 11, 2018
Published For Opposition
Nov 21, 2018
Notification Of Notice Of Publication E-Mailed
Nov 2, 2018
Assigned To Lie
Oct 18, 2018
Approved For Pub - Principal Register
Oct 17, 2018
Examiner's Amendment Entered
Oct 17, 2018
Notification Of Examiners Amendment E-Mailed
Oct 17, 2018
Examiners Amendment E-Mailed
Oct 17, 2018
Examiners Amendment -Written
Apr 19, 2018
Notification Of Priority Action E-Mailed
Apr 19, 2018
Priority Action E-Mailed
Apr 19, 2018
Priority Action Written
Apr 16, 2018
Assigned To Examiner
Jan 19, 2018
New Application Office Supplied Data Entered In Tram
Jan 9, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24